4D Molecular Therapeutics Inc (FDMT NASDAQ) stock market data APIs
$10.0531
-0.93(-9.3%)
as of May 8, 2026
Try our APIs with
free plan!
4D Molecular Therapeutics Inc Financial Data Overview
Price chart is built with
Anychart
4D Molecular Therapeutics, Inc., a late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic Vector Evolution in the Netherlands and the United States. The company's lead product candidate is 4D-150 for the treatment of retinal vascular diseases by providing multi-year sustained production of anti-VEGF from the retina with intravitreal injection, as well as for treating wet age-related macular degeneration and diabetic macular edema. It is also developing 4D-710, which is in early-stage study for the treatment of cystic fibrosis; 4D-175 that is in preclinical stage for treating geographic atrophy; and 4D-725, which is in preclinical stage for the treatment of alpha-1 anti-trypsin deficiency lung disease. 4D Molecular Therapeutics, Inc. has collaboration and licensing agreements with Otsuka Pharmaceutical Co., Ltd. The company was founded in 2013 and is headquartered in EmeryVille, California.
Prev. Close
10.0531
Open
9.1247
High
10.0648
Low
9.0521
52 wk Range
3.02-12.34
Market Cap
530 M
Shares Outstanding
52 276 K
Revenue
88 242 K
EPS
-1.01
Beta
2.759
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with 4D Molecular Therapeutics Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get 4D Molecular Therapeutics Inc data using free add-ons & libraries
Get 4D Molecular Therapeutics Inc Fundamental Data
4D Molecular Therapeutics Inc Fundamental data includes:
- Net Revenue: 88 242 K
- EBITDA: -171 434 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get 4D Molecular Therapeutics Inc Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-05-07
- EPS/Forecast: -0.875
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
4D Molecular Therapeutics Inc News
New
S&P Futures Climb With All Eyes on Key U.S. Jobs Report
June S&P 500 E-Mini futures (ESM26) are trending up +0.46% this morning as investors shrugged off an exchange of fire between the U.S. and Iran and awaited the release of the key U.S. jobs report. Th...
4DMT Announces New Employment Inducement Grants
4D Molecular Therapeutics, Inc. EMERYVILLE, Calif., April 17, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advanc...
4DMT Announces New Employment Inducement Grants
EMERYVILLE, Calif., April 17, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targete...
4DMT Reports FY25 Results, Highlights Progress Across Retinal And Pulmonary Pipeline
(RTTNews) - 4D Molecular Therapeutics (FDMT) has reported full-year 2025 financial results, noting strong operational progress and a narrowed net loss. For 2025, collaboration and license revenue ros...
Get 4D Molecular Therapeutics Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
